Vertex Directors Receive Stock Grants and Options Ahead of Q1 2026 Earnings

Several directors at Vertex Pharmaceuticals Inc. have recently received stock grants and options, as reported in various news articles on Google News. Lloyd Carney and Alan Garber were granted fully vested options (, ). Other directors, including Alan Garber and a director at Vertex (NASDAQ: VRTX), received 2,866 fully vested options (, ). Some directors, such as Alan Garber and a director who received new equity grants (), were also granted RSUs. Additionally, a director was granted 943 RSUs and sold 318 shares (). One director deferred vested shares into stock units (), while another director reported a stock grant and 796-share deferral ().

Related Stocks

• VRTX